Articles related to Nephrology

In a recent study assessing chronic insomnia treatments in hemodialysis patients, no significant difference was observed between CBT-I, trazodone, and placebo in improving Insomnia Severity Index scores. This highlights a critical need for alternative therapeutic approaches in this unique patient population.

Recent studies reveal that adding ezetimibe to lower-intensity statin therapy is as effective as high-intensity statin therapy alone in preventing major cardiovascular events, offering a new approach to lipid management in patients intolerant to high-intensity statins.

Recent evidence suggests that the initiation of treatment with thiazide diuretics carries a more substantial risk for hyponatremia than previously recognized, particularly in the initial months of treatment.

Belzutifan’s FDA approval, following the LITESPARK-005 trial results, represents a significant stride in treating advanced kidney cancer, offering a novel therapeutic option for patients who have exhausted standard treatments.

In the delicate dance of AI and healthcare, a sobering revelation surfaces—predictive models, designed to enhance accuracy in ICU predictions, may inadvertently compromise their own efficacy.

A recent case study stresses the importance of considering Addison disease in patients presenting with long-standing hyperpigmentation. Notably, the patient’s potassium level was found to be 5.7 mmol/L (reference range 3.6–4.8) at admission.